Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio
Shanghai Fosun Pharmaceutical Group Co Ltd cash flow-to-debt ratio. Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of CN¥2.40 Billion could theoretically repay 0% of its total liabilities (CN¥57.97 Billion) in one year. Check 600196 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Cash flow-to-debt ratio of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. Historical debt coverage capacity for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Check 600196 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Shanghai Fosun Pharmaceutical Group Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Shanghai Fosun Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Shanghai Fosun Pharmaceutical Group Co L (600196) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥6.01 Billion | CN¥57.97 Billion | ▲ +33.1% |
| 2024 | 0.08x | CN¥4.48 Billion | CN¥57.53 Billion | ▲ +1.4% |
| 2023 | 0.08x | CN¥4.36 Billion | CN¥56.85 Billion | ▼ -3.5% |
| 2022 | 0.08x | CN¥4.22 Billion | CN¥53.05 Billion | ▼ -9.6% |
| 2021 | 0.09x | CN¥3.95 Billion | CN¥44.92 Billion | ▲ +28.5% |
| 2020 | 0.07x | CN¥2.58 Billion | CN¥37.70 Billion | ▼ -21.6% |
| 2019 | 0.09x | CN¥3.22 Billion | CN¥36.92 Billion | ▲ +9.4% |
| 2018 | 0.08x | CN¥2.95 Billion | CN¥36.96 Billion | ▼ -0.3% |
| 2017 | 0.08x | CN¥2.58 Billion | CN¥32.23 Billion | ▼ -29.7% |
| 2016 | 0.11x | CN¥2.11 Billion | CN¥18.52 Billion | ▲ +23.2% |
| 2015 | 0.09x | CN¥1.62 Billion | CN¥17.53 Billion | ▲ +25.1% |
| 2014 | 0.07x | CN¥1.20 Billion | CN¥16.23 Billion | ▼ -13.7% |
| 2013 | 0.09x | CN¥1.01 Billion | CN¥11.81 Billion | ▲ +31.3% |
| 2012 | 0.07x | CN¥665.52 Million | CN¥10.20 Billion | ▲ +125.0% |
| 2011 | 0.03x | CN¥316.65 Million | CN¥10.92 Billion | ▲ +5.9% |
| 2010 | 0.03x | CN¥203.36 Million | CN¥7.43 Billion | ▼ -52.2% |
| 2009 | 0.06x | CN¥261.87 Million | CN¥4.58 Billion | ▼ -24.0% |
| 2008 | 0.08x | CN¥233.04 Million | CN¥3.09 Billion | ▲ +78.7% |
| 2007 | 0.04x | CN¥131.48 Million | CN¥3.12 Billion | ▼ -31.9% |
| 2006 | 0.06x | CN¥184.91 Million | CN¥2.99 Billion | ▼ -8.1% |
| 2005 | 0.07x | CN¥188.35 Million | CN¥2.79 Billion | ▼ -22.5% |
| 2004 | 0.09x | CN¥205.10 Million | CN¥2.36 Billion | ▲ +27.6% |
| 2003 | 0.07x | CN¥150.14 Million | CN¥2.20 Billion | ▼ -2.4% |
| 2002 | 0.07x | CN¥102.47 Million | CN¥1.47 Billion | ▼ -9.3% |
| 2001 | 0.08x | CN¥68.15 Million | CN¥884.68 Million | ▼ -80.4% |
| 2000 | 0.39x | CN¥138.43 Million | CN¥352.61 Million | ▲ +106.7% |
| 1999 | 0.19x | CN¥38.20 Million | CN¥201.15 Million | ▼ -66.8% |
| 1998 | 0.57x | CN¥66.55 Million | CN¥116.36 Million | — |